Human papillomavirus therapy for the prevention and treatment of cervical cancer

被引：3
作者：
Samir N. Khleif
机构：
[1] Center for Cancer Research, National Cancer Institute, National Naval Medical Center, Building 8, Room 4137, Bethesda, 20892, MD
来源：
Current Treatment Options in Oncology | 2003年 / 4卷 / 2期
关键词：
Cervical Cancer; Cervical Cancer Cell; Cervical Intraepithelial Neoplasia; Hairpin Ribozyme; Recombinant Vaccinia Virus;
D O I：
10.1007/s11864-003-0012-0
中图分类号：
学科分类号：
摘要：
Cervical carcinoma is associated with human papillomavirus infection. Proliferation of cancer cells depends on the continual expression of the E6 and E7 viral oncogenes. This article includes treatment strategies that can interfere with expression or function of the proteins and immunotherapeutic approaches that can eliminate cells that express E6 and E7 proteins. © 2003, Current Science Inc.
引用
收藏
页码：111 / 119
页数：8
相关论文
共 66 条
[1]  
Alani R.M., Munger K., Human papillomaviruses and associated malignancies, J Clin Oncol, 16, pp. 330-337, (1998)
[2]  
Kirnbauer R., Booy F., Cheng N., Et al., Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic, Proc Natl Acad Sci U S A, 89, pp. 12180-12184, (1992)
[3]  
Dvoretzky I., Shober R., Chattopadhyay S.K., Lowy D.R., A quantitative in vitro focus assay for bovine papilloma virus, Virology, 103, pp. 369-375, (1980)
[4]  
Lowy D.R., Schiller J.T., Papillomaviruses: prophylactic vaccine prospects, Biochim Biophys Acta, 1423, pp. M1-M8, (1999)
[5]  
Volpers C., Schirmacher P., Streeck R.E., Sapp M., Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells, Virology, 200, pp. 504-512, (1994)
[6]  
Roden R.B., Hubbert N.L., Kirnbauer R., Et al., Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition, J Virol, 70, pp. 3298-3301, (1996)
[7]  
Kirnbauer R., Taub J., Greenstone H., Et al., Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles, J Virol, 67, pp. 6929-6936, (1993)
[8]  
Suzich J.A., Ghim S.J., Palmer-Hill F.J., Et al., Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas, Proc Natl Acad Sci U S A, 92, pp. 11553-11557, (1995)
[9]  
Jansen K.U., Rosolowsky M., Schultz L.D., Et al., Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation, Vaccine, 13, pp. 1509-1514, (1995)
[10]  
Breitburd F., Kirnbauer R., Hubbert N.L., Et al., Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection, J Virol, 69, pp. 3959-3963, (1995)
1234567